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Loss of heterozygosity of chromosome region 9p21 
occurs commonly and early in sporadic melanoma, 
suggesting the involvement of a tumor suppressor 
gene at this locus in the pathogenesis of this neo-
plasm. Although germline Inutations and deletions of 
the p161NK4 gene located at 9p21 have been reported 
in familial lDelanoma, the relative contributions of 
mutation and deletion in sporadic melanoma are at 
present unclear. In this study, we investigated 26 
cases of sporadic cutaneous melanoma (14 of which 
demonstrated loss of heterozygosity at 9p21) for mu-
tations of p16 lNK4• One tumor with allelic loss of 9p 
contained a CC -7 TT mutation at co dons 57/58, 
altering an arginine to a stop codon, consistent with 
bi-allelic inactivation of p16lNK4 in this case. No 
mutations were identified in any of the other mela-
T he repo rted in cid en cc of human cutancous mela-noma is in creasing worldwide, with a rcsul ting in-crease in morbidity and mortality (MacKic cI al. 1992; MacLennan d ai, 1992; Elder, 1995) . The invo lvcment of a tumor suppressor genc on chromo-
som e 9p21 in the dcvelo pmc nt of melanoma is suggcsted by thc 
fi'equcllt findin g of loss of heterozygosity (LOH) of thi s loclls in 
mcl anoma (Fo ulltain d ai, 1992; Holland cl ai, 1994 ; Isshiki cl ai, 
1994; Wa lkcr el al. 1994; H ealy CI ai, 1995). In addition, linka gc 
studies o n fam ilia l me lanoma sugges t that one of the gcnes respon-
sible for melanoma in these kindreds resides on this area of 
chromosome 9p (C annon-Albri ght el al. 1992; Nancarrow el ai, 
1993) . Loss of 9p21 a lso occurs frequently in other ca ncers, 
in cluding bladder, breast, and brain Oen cl al. 1994; Spruck (!I ai, 
1994; Brenner and Aldaz, 1995) . T h e p 'l () INK.' gene. an inhibi to r of 
cyclin-de pendent kinase-4 that maps to this locus, has been found 
to be mutated fi'equently in }I v.l ri ety of cell lin es, although 
mutatio n rates appear high er in cell lin es th an in primary tum o rs for 
some can cer types (Ca irn s CI ai , 1994; Kamb cI al. 1994a; Nobori cl 
al. 1994; Spru ck cf ai, 1994). Some primary tumors d o, however, 
show hi gh riltes of p16 IN'{" mutation , including pancreatic adeno-
carcin oma and squa m o us ca rc in o ma of the esophagus (Caldas cl ai, 
1994 ; Mori el ai, '\ 994) . In contrast, in other tumo rs such as 
g lioblastoma nlUltiforme and T-ce ll acute lymphoblastic le ukcmia, 
ho mozygo lls deletion of this region rath er than po int mutation 
appears to be a morc frequ ent m cchanism of p1 61NK'1 inac tivation 
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Abbreviation: LOI-I. loss of heterozygosity. 
nom as, or in one benign intradermal nevus with 
atypical features and two Spitz nevi that also showed 
loss of heterozygosity of9p. The inactivation of both 
copies of p16lNK4 in the one case of melanoma adds 
support to the theory that p161NK4 is in~portant in the 
development of sporadic cutaneous melanoma, al-
though allelic loss or other methods of inactivation of 
p161NK4 rather than point mutation appears to be 
nUlllerically lnore illlportant. The low frequency of 
lllutation of p16lNK4 in cases of sporadic lllelanoma 
with loss of heterozygosity of 9p is, however, also 
consistent with there being another tUlllor suppressor 
gene near this locus that is involved in some cases of 
sporadic lDelanolDa. Ke}' words: loss of heterozygosity/ 
helligtl melauocytic nevils/Spitz lIeVIIs/t",tlOr SIIppJ'eSSOJ' getle. 
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(He bert el ai , 1994; Jen el ai, 1994) . In homozygous loss. although 
the deleted area often includes both p16 IN'{,' and the n eighboring 
p151 NKoJIl gene, support for p161NK.1 being the relevant target 
comcs fi'om th c observation of the suppression of cell growth when 
it is introduced into glioma and lun g cells null for this gene (A rap 
cl (fl, 1995; Jin cl al. 199 5). 
A lthough thc identifi ca tion of gennlin e po in t mutations or small 
intrageni c deletion s in the p161NKoJ gene ill some families wi th 
inherited melanoma supports :l causal role for p161NK4 mutation in 
these kindrcds , the rel :ltive cont"ibu tions of pOiJlt mutation or 
de letion of p16 INK.' , or deletion of othe r genes on 9p, in sporadic 
m e lanoma arc at present unclear (Hussussian el ai, 1994; Kamb e/ ai, 
1994b; Ohta cl ai , 1994; Gruis cl ai , 1995a. 1995b; Liu ('I "I , 1995). 
Becau se chrumosome 9p is the most fre qu entl y d ele ted chromo-
some arm in primary cutaneous m e lanoma , and beca usc loss of thi s 
arm occllrs earl y in the developm ent of thi s tumor (being identi fied 
both in ca rl y invasi ve lesions and in potential prec ursor lesions) 
(H eal y el ai, 1995, 1996), we examin ed the pi 6 'NK" gene in 26 
prim<ll'y cut;II1 COUS melanomas. In view of th e bio logic aggressive-
ness of m elanoma and the high degree of genomi c instability even 
in ea rl y lesions, we decided to adopt a cloning strategy as well as 
direc t sequencing ofp16' NK.' , so that any tllmo" heterogeneity with 
respect to p16' N'{.' mutation could be detec ted. In addition, we 
investigated three benign melanocytic les ions with LOH of9p (i. e .. 
two Spitz nevi and one benign intraderma l nevus w ith atypical 
features) for mutation of thi s gene (Healy el ai , 1996). 
MATEIU ALS AND METHODS 
Formalin-fixed. panlAin-embedded tumors Were initially microdissccted 
under 3n in verred n)icro.~cope to rnininl izc contalninarion by strOHl a or 
in f, ltrating lymphocytes. DNA was extracted as outl ined previously from 
rhe tumor and from corresponding norl11al cOlltrol skin or blood (Healy f( 
,d. 1995). T he Ores low thickness of the melanomas CI J superficial spread-
ing. 13 nodlllar) varied fro m 0.8 to 9.0 mm. Screening for mutations in 
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Table I. 
Exon 1 
Exo ll 2 
Exon 3 
Primers Used in Nested PCR for Exons 1, 2, and 
3 of the p161NK4 Gene 
Forwa rd outer primer 
H .. cvcrse o ute r pri ulcr 
Fo rward inner pril11Cr 
Reve rse inn er prinlcr 
Forward outer primer 
R everse outer primer 
Forward in ner prinlcr 
R.eversc inner primer 
Forward o llte r prinle r 
R.eversc o uter prilne r 
Forward inner primer 
H .. evc rse inner p rilll e r 
5 ' -CAGCACCGGAGGAAGAAAG- 3 ' 
5' -GCGCTACCTGCTTCCAATTC-3 ' 
5 ' -TGGCTGGTCACCAGAGGG'T'- 3' 
5 ' - AAACTTCGTCCTCCAGAGTCG- 3 ' 
5 ' -GGAAATTGGAAACTGGAAGC - 3 ' 
5 ' -GGCTGAACTTTCTGTGCTGG - 3 ' 
5 ' -GCTTCCTTTCCGTCA 'T'GCC - 3 ' 
5 ' - TC1'GAGCTT1'GGAAGCTC1' - 3 ' 
5 ' -CCATTGCGAGAAC'I'T1'ATCC- 3 ' 
5 ' -TGGACAT1'1'ACGGTAGTGGG-3 ' 
5 ' -GGA1'GTGCCACACATCTTTG-3 ' 
5 ' - AGTTGTGGCCCTGTAGGAC - 3 ' 
exom 1 and 3 was initially by dideoxy fi nge rprinting in both directions, with 
sequencing of samples that disp layed band shifts or extra bands (S'" 'kar et ai , 
1992; Blaszyk Cf ai, :19 95 ), whereas all samples were sequenced for exon 2. 
Two approaches were used for p16 ' NK.' sequencing, namely c1 0lling (exon 
2) and direct seq uencing (exons 1, 2, and 3). 
DNA Amplification/Cloning of Ex on 2 Initial polymerase chain reac-
tion (PCR.) was carried out in 25-iJ.1 reac tions us ing 400-pmo l primers 
(forward primer 5' -GGAAA TTGGAAACTGGAAGC-3' , reverse primer 
5' -TCTGAGCTTTGGAAGCTCT-3') (Kamb cf ai, '1994a) , 300-ng 
genomic DNA, 200 iJ.M dNTPs, 10% dimethylsulfoxide, 2. 5 mM MgC I2' 
and 0.5 U of Taq polymerase (Advanced Biotechn ique, Leatherhead, UK) . 
Cycle parameters were 94 °C X 30 s, 51 °C X 1 min, 72 °C X 1 min for 40 
cycles, and a fi nal extension of 1 0 min at 72°C during the last cycle. Three 
microliters of product (length 509 bp) was further amplified under identica l 
conditions for 10 cycles before cloning into a pcru r vec tor (TA cloning kit; 
Invitrogen , Leek, T he Netherlands) and transfo rmation in to XL-1 Blue 
Escherichia co li (Stratagene, Cambridge, UK) according to the manufactur-
ers' instructions. Colonies with inserts were identified and expanded, and 
DNA was ex tracted by the alkaline lysis method before purification of the 
insert by 1 % agarose gel electrophoresis foll owing EcoKI digestion of the 
plasmid DNA. 
DNA Amplification/Nested PCR ofExons 1, 2, and 3 Primers in the 
intron sequences (both previously published in Kamb ef ai, 1994a, and 
newly designed; Table I) were employed to allow nested PCR. amplific<l -
rion using conditions as outlined ea rli er, exccpt that 100 ng of genomic 
DN A was uscd in the firs t PC R , both amplifications consisted of 40 cycles, 
and annealing temperatures were 55°C for exons 1 and 3 . T lu'ee micro li ters 
of the product fi'om the outer PC R. was used for ampli fication in the inner 
PCR, and the fina.l product (lengths 297 bp, exon 1; 419 bp, exon 2; and 
151 bp, exon 3) was purified by 1% agarose gel electrophores is. 
Cycle Sequencing After 1°;', agarose gel purification , bands were cut out 
and 11 iJ.1 of product DNA was sequenced using forward and reverse inner 
primers (end-labeled with y12p_ATP) with a standard cycle sequ encing kit 
(SequiTherm; Epicenter Technologies, Madison, W I), according to the 
manufacturer's instructions. Because of the GC-rich nature of the gene, 
products from the cycle sequencing PCR were incub<lted <lt 37°C X 30 min 
with 1 U of terminal transferase (Promega, Southampton , UK) and excess 
dNTPs to extend nontcrminated products (Brcnner and A1daz, 1995) . 
Products were subsequently electrophoresed through 5% sequencing gels 
and visualized by autoradiography. Samples in which putative mucations 
were identified were reamplified using nested PCR., starting fro m genomic 
DNA, and resequenced for confirmation of the mutation . 
Dideoxy Fingerprinting of Exolts 1 and 3 The rcaction mixture and 
PCR protocol were as documented fo r cycle sequencing, except tha t only 
dTTP terminationm.ixture was used. As per SarkaI' 1'1 al (1 992) , 42 iJ.1 of stop 
solution (95% formamide, 20 mM ethylenediamine tc traacetic ac id, and 
1) .5% each of xylene cyanol and bromophenol blue) was added to 6 iJ.1 of 
sequencing m ix, and this mixturc was heated at 95 °C for 5 min and chilled 
on icc for 10 min. Two microli te rs was then loaded on a 6'Y., polyacrylamide 
gel containing 10% glycerol and electropho resed at 30 W at room temper-
ature, cooling with a fan, for 6 - 8 h. T he ge ls were dried , and bands were 
visua lized by autorad iography. 
LOH Analysis All samples had becn in vestigated previously fo r LO H of 
chromosome arm 9p using microsate lli tc markers that flank the p 16' N1{4 
gene (D9S162 and D9S 171; R.csearch Genetics, HUlltsv ille, AL) (Weissell-
bach ef ai , 1992; Healy cf " I, 1996). Fourteen ofthc 26 melanomas had LO H 
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Figure 1. A CC -> TT tallden, base mutation in exon 2 (co dons 
57/58) ofp161NI(4, (a) Sporadic primary cutaneous melanoma: (b) wild-type 
seq ue nce. 
of 9p, with no evidence of LOH of this 3rm in the other 12 melanomas. 
Two Spitz nevi and one benign in tradermal nevus with aLl elic loss on 9p 
were also investigated fo r p 'I 6 'NI{ ,' mutations (Healy CI ai, 1996) . 
RESULTS 
Using an initial nes te d PCR ap proach with subsequ ent cycle 
seque n cing, w e detected a CC -,> TT double b ase mutation at 
codon s 57 and 58 of p1 6 1 NK~ in one n o du.lar m elanoma (Bres low 
thickness 5.0 mm). T h e control tissu e in this case contain e d a 
wild-type sequ e n ce. Beca use t his m e lan oma demonstrated a hem-
izygou s d e letion with both marke rs D9S162 and D9S171, it was 
though t likely that the mutatio n was a tandem base c hange (i.e., o n 
adjacent nucl eoti d es) on th e o n e reta ined cop y of p16'NK~, leading 
to an alteration of the a mino acid sequ en ce from A I;g -,> stop codo n . 
To confirm tlus, we seque n ced singl e colonies obtained throug h 
cloning ofp161NK4 fro m tlus m e lan oma. T h e identification of both 
alte rations in DNA £i'om one clone d emonstrated that both muta-
tions were on the one alle le ofp16 1 NK~ (Fig 1). Extra bands or band 
shifts on d ideoA}' fin gerprinting were identified in nin e tumors; 
h owever , u sing the neste d P C R approac h , no mutatio ns , insertions, 
or intra genic d e letions of exons 1, 2 , and 3 wer e ide ntifie d in the 
oth e r 25 melanomas (13 with LOH of9p, 12 with re tention of both 
copies of 9p) o r in the two Spitz nevi and the be nign intradermal 
n evus with LOH of 9p. In two m e lanoma s, optimal sequences for 
exon 1 could n ot b e o btained . In four cases (three m e lanomas and 
o n e Spitz nevus), a G to C transversion in the 3' -untranslated 
region was ide ntified 29 nucleo tides 3 ' to the stop cod o n. T his 
alteration was present in th e n ormal con trol ti ssu e (one control was 
ho m ozygous for this c han ge) and was o n the retained alle le in one 
h e terozygous case, b ut o n the dele te d alle le in ano ther h eterozy-
gou s case. 
To examin e for tUl11 0r h eterogen e ity and th e possibi lity of 
individual clon es h arbo ring difFe rent p161NK4 mutations, we p er-
form e d seque n cing of sin g le clones fi'om seven m e lan o m as , one 
Spitz n evus , and control sampl es . Alteration s wer e ide ntifi ed in five 
m e lanomas, fo u r cases of n on lesiona l skin (con tro l samples), and 
one Spitz nevus. In one m e lanoma (with LOH of 9p), seven 
diffe rent alter~tiotlS were seen: a C -,> T at codon 93 in clone 1, an 
A -,> G a t cod o n 92 in clone 3, ~ G -7 A at codon 11 2 in clone 5, 
a G -,> A at codon 97 and 3n A -,> G at codon 152 in clone 7 , and 
a G -,> A at codon 54 and a G -,> A at codon 62 in clo n e 10. To 
e xamine w h e the r the~e results could have ari sell as a r esult ofPCR 
or c10 lling artifacts , we pe r formed seq u e nc ing o f coloni es o btaine d 
fi'om blood DNA fi'om four othe r subj ects without melanoma and 
without a known pre disposition to m e lano m a. Altera tio ns were 
d etected in all four individua ls. C lo nes ti'om o n e indiv idual's b lood 
contained a T -,> C c han ge at codon 142 in clon e 9, a n A -,> G at 
codon 14 1 in clone 10, and a w ild-type sequ e nce in clone 4. O n e 
clone from each o f the oth e r th ree indiv iduals contain e d a sin gle 
320 HEALY ET AL 
(nonidcntical) point mutati on, whilc othcr clones from cach of 
these three individuals all gave a wi ld- type sequcnce. In all four 
blood samplcs, nesred P C R .. revealed a wi ld-typc sequcnce. 
DISC USSION 
Gcncs invo lved ill hered itary can cer syndromes are often in volved 
in th e pathogcnesis of sporadic cancers of the samc patho logic type 
(Li, 1991) . In this study, only one of 26 cutaneous m elano mas 
con ta ined a mutation within the p16 INK" gene. T his mutation 
resulted in a truncated protein, and because this case also had LOH 
of 9p, both a lle les of p1 6IN'{4 were inactivated in this tumor, 
providing strong evidence that this gene was th e relevant target 
within the deleted are;). The finding of a CC --'> TT double base 
cbange in thjs prim ary tumor is compatiblc with thc mutation 
arising ill I) illil as a result of ultraviole t radiation. Our low mutation 
ra te is similar to the rcsults ofOhta et til (19 94), who did no t idc ntifY 
any mutations of p 16'NK.' in 13 sporadic cutaneous melanomas or in 
17 uveal m elanomas, an d to those of Gru is eI "I (1995b) , who found 
mutation s in five of 34 me lanomas, all of w hich occu rred in exon 
2. Unfortunately, as matchcd norma l DNA wa s not available fo r 
the samples of Gruis et til, the germline status of p 161NK.' in thesc 
cases wa s not known, and so it is possible that the mclan omas in 
question might have arisen as a result of gcrmlinc or somatic 
p16' NK4 mutations (Gruis et " /, 1995b). The G to C transversion in 
the 3'-ulltran sla ted region in four of oUI· cases has not bce n 
identified prcviollsly in cutaneo us melanomas, but represents a 
polymorphism beca use it was in the control tissue. 
O Uf results suggest th at LOI-! of 9p is a more frequent m echa-
nism of p16' NK4 ina ctivation than is mutatio n or in tragenic in ser-
tion/ de letion. Additionally, in activation of this gene in sporadic 
melanoma may o ccur via CpG methylation, a process that has been 
dcmonstrated in other human cancers (Gonzalez- Z ulueta c( ti l. 
1995; Herman c( ai, 1995; Merlo el (/1, 1995), and homozygous 
deletion of the p16' NK4 gene (Fountain et ti l, 1992; Caldas e/ til, 
1994; H e bert eI ti l, 1994; H o lland et til. 1994; Iss hiki ef ti l, .( 994; Jen 
. et II I, 1994; Walke r ct III, 1994). We have shown previo usly that 
almost half of all cutan eous melanom as lose one copy of 9p at loci 
near the p161NK .' gen e (H ealy el til, 1995); this suggests that large 
homozygous dclcti om can acco unt for on ly up to 50'X, of cases of 
p16 IN'(. ' inactivation. (The reasonin g is that evcn w ith stro mal 
contamination , th e detcction of LOH implies that o ne rather thall 
bo th alleles is lost, leaving a ma x.imum of 50% of cascs du e to 
homozygous loss). It is possible, h owever , that homozygous dele-
tions co uld account for a hi gher percentage of cascs if the ho mozy-
gously dele tcd 'H·ca wel'e restricted to the region within the markers 
D95162 and D95171 . We ca nllot discoun t this possibi li ty, as min o r 
stromal contamination in the microdissected specimcns could give 
a w ild-type sequcnce if the melanoma cells were null for p1 61N1(.I. 
A second tumor suppressor gene located nearby could also be the 
target of the 9p loss in some cases of me lanoma . Man y de letio ns on 
9p in m elanoma encompass both p1 61N1(4 and p15 1NK4B (Kanlb e( 
ti l , 1994a), and Puig ct (/1 (1995) reported that LOH fo r 9p markers 
in fou r of25 cutaneous melanomas w ith 9p loss d id not involve the 
p16' NK" locus. In addition, Holland et " I ("1994) identitied two areas 
of cOl11mo n Joss on either side of the intcrferon gene cluster in fi ve 
melanomas, implying the involvem ent of mo re than one tumor 
suppressor gene on 9p in c utaneous melanoma. 
T he artifactlwl Illutations that resulted fi'ol11 c.:Ionin g before 
sequencing m eri t comment. R ecent work by Kanjil al et III ( 1995), 
usin g a simi.l ar approach to look for p53 mutations in non-
m elanoma skin cancer, dcmonstrated multiple sequ ence changes of 
p53 in these tumors and in adja cent nOllmali gnant skin , which the 
authors interpreted as e vidence for field ca ncerization. Altho ugh 
the protocols used were not identical , o llr results on p161NK.' 
caution that, for this gene at least, such changes may arise after PC R 
and cloning. 
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